Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY26 outlook

Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY26 outlook

Jan 30, 2026

Post navigation

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: